| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-10-05 | NCT07859228 A Phase 1 Study of HCB303 in Participants With Advanced Malignancies | Phase 1 | Not Yet Recruiting |
| Phase 1 | 3 | |
| Phase 1/2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT06771622 | Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With… | Solid Cancer | Active, Not Recruiting | 2026-02-04 |
| Phase 1 | ||||
| NCT06487624 | An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects… | Advanced Solid Tumor | Recruiting | 2026-04-13 |
| NCT05892718 | A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in… | Advanced Solid Tumor | Recruiting | 2026-02-04 |
| NCT07859228 | A Phase 1 Study of HCB303 in Participants With Advanced Malignancies | Advanced Malignancies | Not Yet Recruiting | 2026-10-05 |
Hodgkin Lymphoma (1) · Non-Hodgkin Lymphoma (1)